What dose and fractionation would you deliver to the sole of the foot in a patient with multifocal cutaneous DLBCL that is resistant to systemic therapy?
2 Answers
Mednet MemberInvited Expert
Radiation Oncology · Duke University Medical Center
Answered on
We need some more information here. Does multifocal mean the patient has multiple skin lesions? The diagnosis of cutaneous DLBCL is also somewhat ambiguous. Is this cutaneous DLBCL leg type, a specific entity in the WHO pathology classification, or perhaps the older WHO classification is being used ...
Join for free or sign in to see the full answer
Mednet MemberInvited Expert
Radiation Oncology · University Hospital Basel
Answered on
Is this perhaps a leg-type DLBCL?
Leg-type DLBCLs tend to show an aggressive pattern of growth and recurrence.
The primary question is if you think there's still a chance to cure this patient. Even if resistance to systemic therapy is observed, there may still be options, including stem-cell transp...
Join for free or sign in to see the full answer